Crohn's disease trials in Denmark

In Denmark 22 Also abroad 422

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A clinical study of MK-7240 for the treatment of Crohn’s disease (MK-7240-008)
Where
Herlev, Odense C
Age
18 years and over
People
567 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2024-518296-56-00 · EU 2024-518296-56-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Where
Herlev, Odense C
Age
16 years to 80 years
People
1,200 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06430801 · EU 2023-508636-61-00
Phase 4Enrolling by invitation
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Where
Aalborg, Esbjerg, Hvidovre, Nyborg, Odense C, Vejle
Age
18 years and over
People
166
Run by
Odense University Hospital
See details and how to joinNCT06788340 · EU 2024-517123-39-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Aarhus, Copenhagen, Gistrup, Odense, Vejle
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Where
Aarhus C, Esbjerg, Gistrup, Herlev, Hilleroed, Hvidovre, København NV, Odense C
Age
18 years and over
People
530 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07499232
Phase 2Taking people
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Where
Esbjerg, Gistrup, Hilleroed, Hvidovre, Koege, Odense C
Age
18 years to 75 years
People
268 worldwide
Run by
Takeda
See details and how to joinNCT06233461 · EU 2023-506704-14-00
Phase 4Taking people
A study to measure mirikizumab levels in breast milk of lactating participants receiving mirikizumab therapeutically for an approved indication
Where
Aarhus N, Slagelse
People
16 worldwide
Run by
Eli Lilly & Co.
See details and how to join2025-522362-78-00 · EU 2025-522362-78-00
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Where
Herlev
Age
16 years to 80 years
People
600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06819878 · EU 2024-513053-69-00
Phase 2Taking people
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
Where
Aarhus N, Copenhagen Nv, Copenhagen Oe, Herlev, Odense C
Age
18 years and over
People
160 worldwide
Run by
Agomab Spain S.L.U.
See details and how to join2026-525197-19-00 · EU 2026-525197-19-00
Phase 3Taking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Hvidovre
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
Phase 2Taking people
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Where
Aarhus N, Copenhagen Nv, Odense C
Age
18 years to 75 years
People
590 worldwide
Run by
AbbVie
See details and how to joinNCT06548542 · EU 2024-513009-30-00
No phaseTaking people
Feasibility of a Minimally Invasive Diagnostic Algorithm in Suspected Crohn's Disease
Where
Esbjerg, Odense C, Svendborg, Vejle
Age
18 years to 40 years
People
165 worldwide
Run by
Esbjerg Hospital - University Hospital of Southern Denmark
See details and how to joinNCT06882993
Phase 3Taking people
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
Where
Aalborg, Aarhus N, Copenhagen Nv, Copenhagen Oe, Esbjerg, Herlev, Hilleroed, Hvidovre, Odense C
Age
18 years and over
People
302 worldwide
Run by
Janssen Cilag International
See details and how to join2025-521590-13-00 · EU 2025-521590-13-00
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Hvidovre
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
Phase 3Taking people
A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
Where
Copenhagen Oe, Gistrup, Hvidovre
Age
18 years to 65 years
People
396 worldwide
Run by
Takeda
See details and how to joinNCT06227910 · EU 2023-509391-42-00
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Aalborg, Esbjerg, Hilleroed, Hvidovre, Koege, Odense C
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
Phase 4Taking people
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
Where
Aarhus N, Copenhagen Nv, Herlev, Hilleroed, Hvidovre, Koege, Randers Noe
Age
18 years to 80 years
People
304 worldwide
Run by
Alimentiv Inc.
See details and how to joinNCT06257706 · EU 2023-509096-16-00
No phaseTaking people
Extended Mesenteric Resection in Ileocecal Crohn's Disease.
Where
Odense
Age
18 years and over
People
204
Run by
Odense University Hospital
See details and how to joinNCT06324838
No phaseTaking people
Magnesium in Gastrointestinal Disease
Where
Aarhus N
Age
18 years and over
People
120
Run by
University of Aarhus
See details and how to joinNCT07338565
Phase 2Taking people
Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases
Where
Odense
Age
18 years to 75 years
People
200
Run by
Odense University Hospital
See details and how to joinNCT04924270
No phaseNot yet taking people in Denmark
OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity
Where
Hvidovre
Age
18 years and over
People
40
Run by
Andreas Munk Petersen
See details and how to joinNCT07240181
No phaseNot yet taking people in Denmark
Post Operative Hospital at Home After Colorectal Surgery
Where
Hillerød
Age
18 years and over
People
20
Run by
Nordsjaellands Hospital
See details and how to joinNCT07113717